Results 181 to 190 of about 109,974 (359)

Intravitreal anti‐vascular endothelial growth factor injections and risks of stroke in patients with neovascular age‐related macular degeneration—A registry‐based cohort study

open access: yesActa Ophthalmologica, EarlyView.
Abstract Background Intravitreal Anti‐Vascular Endothelial Growth Factor (VEGF) rescues retinal vasculatures and prevents disease progression in patients with neovascular Age‐Related Macular Degeneration (nAMD). However, systemic anti‐VEGF may increase the risk of thromboembolic related complications including stroke and TIA. This study aims to explore
A. H. Falemban   +5 more
wiley   +1 more source

Prescribing trends and patterns for antihypertensive agents in primary healthcare settings in Qatar: a retrospective observational study. [PDF]

open access: yesJ Pharm Policy Pract
Abdelkader NN   +6 more
europepmc   +1 more source

Pharmacokinetics of nipradilol (K-351), a new antihypertensive agent, in human.

open access: bronze, 1985
Mitsuo Yoshimura   +5 more
openalex   +2 more sources

Continuity of care and risk of vision loss in patients with newly developed macular degeneration

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Neovascular age‐related macular degeneration (AMD) is a major cause of vision loss. Effective treatment requires sustained care, which may be influenced by continuity of care (COC). Understanding this association is crucial for improving patient outcomes.
In Hwan Cho   +5 more
wiley   +1 more source

Periodontitis and atherosclerotic cardiovascular disease: A critical appraisal

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract In spite of intensive research efforts driving spectacular advances in terms of prevention and treatments, cardiovascular diseases (CVDs) remain a leading health burden, accounting for 32% of all deaths (World Health Organization. “Cardiovascular Diseases (CVDs).” WHO, February 1, 2017, https://www.who.int/news‐room/fact‐sheets/detail ...
Maria Clotilde Carra   +3 more
wiley   +1 more source

Therapeutic Potentials of Selected Antihypertensive Agents and Their Fixed-Dose Combinations Against Trastuzumab-Mediated Cardiotoxicity. [PDF]

open access: yesFront Pharmacol, 2020
Olorundare OE   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy